LLY241122P625000
- 0.00
- 0.000.00%
Eli Lilly and Co Newsroom
Wells Fargo Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,000
Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop -- Barrons.com
Evercore Maintains Eli Lilly and Co(LLY.US) With Hold Rating
BMO Capital Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Cuts Target Price to $1,010
Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $975
Barclays Keeps Their Buy Rating on Eli Lilly & Co (LLY)
Wolfe Research Initiates Coverage On Eli Lilly With Outperform Rating, Announces Price Target of $1000
Eli Lilly Analyst Ratings
Wolfe Research Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Cuts Target Price to $1,000
Daiwa Adjusts Price Target on Eli Lilly & Co. to $900 From $940, Maintains Outperform Rating
Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $975
Truist Financial Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,029
Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $975
Deutsche Bank Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,015
Eli Lilly Analyst Ratings
Redburn Atlantic Adjusts Price Target on Eli Lilly to $700 From $640, Maintains Neutral Rating
Jefferies Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Cuts Target Price to $994
A Quick Look at Today's Ratings for Eli Lilly and Co(LLY.US), With a Forecast Between $970 to $1,146
Barclays Maintains Overweight on Eli Lilly, Lowers Price Target to $975
A Quick Look at Today's Ratings for Eli Lilly and Co(LLY.US), With a Forecast Between $975 to $1,100